IDURSULFASE

IDURSULFASE was reported 3986 times

IDURSULFASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MUCOPOLYSACCHARIDOSIS II 39 0.8298
1 MUCOPOLYSACCHARIDOSIS 5 0.3333
2 PUNCTURE SITE INFLAMMATION 6 0.2727
3 PUNCTURE SITE OEDEMA 5 0.2632
4 EPIPHYSIODESIS 3 0.2143
5 URINARY GLYCOSAMINOGLYCANS INCREASED 5 0.1852
6 MUTAGENIC EFFECT 4 0.1250
7 CONGENITAL OSTEODYSTROPHY 4 0.1026
8 PUNCTURE SITE BRUISE 5 0.0980
9 BODY HEIGHT INCREASED 47 0.0959
10 ADENOIDAL DISORDER 24 0.0923
11 VIITH NERVE INJURY 6 0.0741
12 VASCULAR ACCESS SITE EXTRAVASATION 6 0.0690
13 CARDIAC VALVE THICKENING 4 0.0678
14 GASTROSTOMY FAILURE 2 0.0645
15 BRAIN STEM AUDITORY EVOKED RESPONSE ABNORMAL 3 0.0638
16 PATIENT UNCOOPERATIVE 29 0.0612
17 PUNCTURE SITE PAIN 13 0.0560
18 INFUSION SITE DRYNESS 3 0.0556
19 ADENOIDAL HYPERTROPHY 20 0.0529
20 CATHETER SITE DISCOLOURATION 6 0.0492
21 INTENTIONAL REMOVAL OF DRUG DELIVERY SYSTEM BY PATIENT 3 0.0462
22 SLEEP STUDY 3 0.0462
23 TRACHEOSTOMY MALFUNCTION 9 0.0435
24 TOE WALKING 5 0.0427
25 EAR TUBE INSERTION 11 0.0372
26 BACTERIAL TRACHEITIS 3 0.0370
27 CATHETER SITE OEDEMA 4 0.0367
28 TRACHEOSTOMY INFECTION 4 0.0328
29 SHUNT MALFUNCTION 9 0.0318
30 TRACHEOMALACIA 12 0.0304
31 CATHETER SITE SWELLING 26 0.0278
32 APPLICATION SITE EXTRAVASATION 2 0.0267
33 TRACHEAL STENOSIS 13 0.0256
34 ENDOTRACHEAL INTUBATION COMPLICATION 15 0.0254
35 CATHETER SITE BRUISE 8 0.0242
36 ADENOIDECTOMY 9 0.0232
37 PHARYNGOTONSILLITIS 5 0.0222
38 DEVELOPMENTAL REGRESSION 3 0.0221
39 BLOOD IMMUNOGLOBULIN E ABNORMAL 2 0.0220
40 TESTICULAR TORSION 3 0.0207
41 FRONTAL LOBE EPILEPSY 2 0.0206
42 FEEDING TUBE COMPLICATION 6 0.0193
43 POOR VENOUS ACCESS 196 0.0189
44 CATHETER SITE SCAB 2 0.0187
45 FEMORAL HERNIA 2 0.0185
46 LARYNGEAL STENOSIS 10 0.0173
47 INFUSION SITE INJURY 3 0.0170
48 PICA 3 0.0167
49 MACROGLOSSIA 9 0.0164
50 BODY TEMPERATURE ABNORMAL 30 0.0163
51 FEMOROACETABULAR IMPINGEMENT 2 0.0161
52 ADENOIDITIS 2 0.0159
53 BRONCHOMALACIA 2 0.0152
54 GASTROSTOMY TUBE SITE COMPLICATION 3 0.0150
55 DISTAL INTESTINAL OBSTRUCTION SYNDROME 5 0.0148
56 DRUG SPECIFIC ANTIBODY ABSENT 3 0.0147
57 TONSILLAR DISORDER 16 0.0142
58 DISCOURAGEMENT 32 0.0137
59 FEEDING TUBE USER 5 0.0137
60 DEVICE COMPONENT ISSUE 2 0.0136
61 INFUSION RELATED HYPERSENSITIVITY REACTION 8 0.0133
62 CARPAL TUNNEL DECOMPRESSION 14 0.0133
63 TONSILLAR HYPERTROPHY 22 0.0131
64 MUSCULOSKELETAL DEFORMITY 3 0.0128
65 HYDROCEPHALUS 69 0.0127
66 CATHETER SITE EXTRAVASATION 5 0.0125
67 INTELLECTUAL DISABILITY 19 0.0125
68 AORTIC VALVE THICKENING 2 0.0124
69 CATHETER SITE WARMTH 2 0.0123
70 KNEE DEFORMITY 18 0.0121
71 DOSE CALCULATION ERROR 7 0.0119
72 UMBILICAL HERNIA 54 0.0115
73 TRACHEAL DISORDER 6 0.0115
74 CATHETER SITE ABSCESS 2 0.0115
75 RETINITIS PIGMENTOSA 3 0.0115
76 VASCULAR DEVICE INFECTION 51 0.0112
77 CATHETER SITE THROMBOSIS 3 0.0109
78 OTORRHOEA 19 0.0109
79 INGUINAL HERNIA 65 0.0107
80 CENTRAL VENOUS CATHETER REMOVAL 5 0.0107
81 MEDICAL DEVICE SITE HAEMORRHAGE 3 0.0106
82 GASTROSTOMY 16 0.0103
83 INFUSION SITE INFLAMMATION 7 0.0099
84 DEVICE RELATED BACTERAEMIA 3 0.0097
85 OTITIS MEDIA 32 0.0097
86 VENOUS INJURY 9 0.0096
87 OTITIS MEDIA CHRONIC 4 0.0095
88 CATHETER SITE INJURY 2 0.0094
89 INCREASED BRONCHIAL SECRETION 24 0.0094
90 FEBRILE INFECTION 11 0.0093
91 TONSILLAR INFLAMMATION 3 0.0093
92 APPLICATION SITE OEDEMA 3 0.0093
93 LARYNGOMALACIA 3 0.0090
94 CROUP INFECTIOUS 7 0.0089
95 CATARRH 8 0.0088
96 PRODUCT AVAILABILITY ISSUE 199 0.0087
97 CONTINUOUS POSITIVE AIRWAY PRESSURE 2 0.0087
98 STRIDOR 25 0.0085
99 RESPIRATORY SYMPTOM 24 0.0084
100 OBSTRUCTION 33 0.0083
101 OTITIS MEDIA ACUTE 6 0.0082
102 WALKING DISABILITY 17 0.0081
103 CATHETER SITE PAIN 21 0.0081
104 EXCESSIVE CERUMEN PRODUCTION 5 0.0081
105 ADMINISTRATION SITE EXTRAVASATION 8 0.0080
106 CENTRAL VENOUS CATHETERISATION 24 0.0079
107 TONSILLECTOMY 13 0.0078
108 RESPIRATORY TRACT INFECTION VIRAL 18 0.0077
109 RESPIRATORY RATE DECREASED 24 0.0076
110 INFUSION SITE EXTRAVASATION 47 0.0075
111 INFUSION SITE RASH 10 0.0073
112 INFUSION SITE OEDEMA 6 0.0072
113 EAR INFLAMMATION 2 0.0069
114 CATHETER SITE HAEMATOMA 2 0.0068
115 VEIN RUPTURE 11 0.0066
116 TRACHEITIS 5 0.0066
117 CATHETER SITE ERYTHEMA 14 0.0065
118 VEIN COLLAPSE 5 0.0065
119 MEDICAL DEVICE SITE INFECTION 4 0.0064
120 EAR HAEMORRHAGE 13 0.0064
121 GRIMACING 5 0.0064
122 SUSPECTED COVID-19 21 0.0064
123 ENDOCARDITIS BACTERIAL 5 0.0064
124 CATHETER SITE INFECTION 24 0.0063
125 OXYGEN SATURATION ABNORMAL 18 0.0063
126 INFUSION SITE HAEMATOMA 3 0.0063
127 CATHETER SITE DISCHARGE 7 0.0062
128 ADMINISTRATION SITE SWELLING 2 0.0062
129 NEUROLOGICAL DECOMPENSATION 14 0.0060
130 DEVELOPMENTAL HIP DYSPLASIA 5 0.0060
131 CATHETER SITE IRRITATION 2 0.0060
132 CARPAL TUNNEL SYNDROME 84 0.0060
133 COVID-19 IMMUNISATION 5 0.0060
134 CATHETER PLACEMENT 11 0.0059
135 INFUSION RELATED REACTION 389 0.0059
136 VARICELLA 14 0.0059
137 CERVICAL SPINAL STENOSIS 10 0.0058
138 ENTEROVIRUS INFECTION 5 0.0058
139 INFUSION SITE DISCOMFORT 6 0.0058
140 BRONCHIAL OBSTRUCTION 8 0.0057
141 ANOXIA 2 0.0057
142 CYTOMEGALOVIRUS HEPATITIS 2 0.0056
143 UPPER AIRWAY OBSTRUCTION 5 0.0056
144 CATHETER SITE HAEMORRHAGE 14 0.0056
145 FOREIGN BODY ASPIRATION 4 0.0055
146 CERVICAL CORD COMPRESSION 2 0.0055
147 RESPIRATORY TRACT OEDEMA 4 0.0054
148 PRODUCT DISTRIBUTION ISSUE 50 0.0054
149 CATHETER SITE INFLAMMATION 3 0.0053
150 MOANING 6 0.0053
151 DENGUE FEVER 12 0.0052
152 CEREBRAL VENTRICLE DILATATION 6 0.0052
153 HEARING DISABILITY 2 0.0051
154 INSURANCE ISSUE 78 0.0051
155 RHONCHI 7 0.0051
156 DEVICE RELATED INFECTION 78 0.0051
157 GRUNTING 3 0.0050
158 DEPENDENCE ON RESPIRATOR 2 0.0050
159 VASCULAR ACCESS COMPLICATION 4 0.0049
160 PHARYNGEAL INFLAMMATION 6 0.0049
161 INCORRECT DRUG ADMINISTRATION RATE 21 0.0049
162 NEURODEGENERATIVE DISORDER 3 0.0049
163 LIP DISCOLOURATION 6 0.0048
164 VITAL FUNCTIONS ABNORMAL 4 0.0047
165 INFUSION SITE IRRITATION 6 0.0047
166 HEARING AID USER 2 0.0047
167 CYANOSIS 71 0.0045
168 INFUSION SITE URTICARIA 3 0.0045
169 INCREASED UPPER AIRWAY SECRETION 23 0.0045
170 CYTOGENETIC ABNORMALITY 5 0.0044
171 CATHETER SITE RASH 2 0.0044
172 BODY TEMPERATURE INCREASED 88 0.0043
173 NUTRITIONAL CONDITION ABNORMAL 3 0.0043
174 SECRETION DISCHARGE 53 0.0042
175 RESPIRATORY DISORDER 126 0.0042
176 TRACHEOSTOMY 6 0.0042
177 INFUSION SITE SWELLING 26 0.0041
178 RHINOVIRUS INFECTION 16 0.0041
179 FEBRILE CONVULSION 5 0.0041
180 DEVICE RELATED THROMBOSIS 4 0.0041
181 DEVICE INFUSION ISSUE 10 0.0040
182 CATHETER SITE RELATED REACTION 3 0.0040
183 NASAL PRURITUS 5 0.0040
184 DEVICE RELATED SEPSIS 8 0.0040
185 INFUSION SITE HAEMORRHAGE 13 0.0039
186 PARAINFLUENZAE VIRUS INFECTION 6 0.0039
187 RESPIRATORY RATE INCREASED 35 0.0039
188 TRACHEOBRONCHITIS 3 0.0039
189 EAR INFECTION 103 0.0039
190 BRONCHOSPASM 55 0.0039
191 CARDIOPULMONARY FAILURE 15 0.0038
192 GASTROINTESTINAL VIRAL INFECTION 4 0.0038
193 RESPIRATORY DISTRESS 106 0.0038
194 METAPNEUMOVIRUS INFECTION 3 0.0038
195 LIMB DEFORMITY 6 0.0038
196 PNEUMONIA MYCOPLASMAL 3 0.0038
197 CORYNEBACTERIUM INFECTION 2 0.0037
198 EXCESSIVE GRANULATION TISSUE 3 0.0037
199 EAR DISORDER 17 0.0037
200 BRONCHOSTENOSIS 2 0.0037
201 RESPIRATORY TRACT INFECTION 95 0.0036
202 NASAL DISCHARGE DISCOLOURATION 5 0.0036
203 MIDDLE EAR EFFUSION 8 0.0036
204 HAND-FOOT-AND-MOUTH DISEASE 3 0.0036
205 ANTIBODY TEST POSITIVE 6 0.0036
206 MITRAL VALVE PROLAPSE 6 0.0036
207 SPINAL DEFORMITY 6 0.0036
208 TYMPANIC MEMBRANE PERFORATION 6 0.0035
209 UNDERWEIGHT 7 0.0035
210 RHINITIS 28 0.0035
211 CRANIOSYNOSTOSIS 3 0.0035
212 PHARYNGITIS 43 0.0035
213 COMPLICATION ASSOCIATED WITH DEVICE 50 0.0034
214 CELLULITIS ORBITAL 2 0.0034
215 FOOD REFUSAL 3 0.0034
216 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
217 HEART RATE ABNORMAL 19 0.0034
218 GASTRIC INFECTION 13 0.0034
219 LIVEDO RETICULARIS 7 0.0033
220 CARDIAC VALVE DISEASE 19 0.0033
221 MOUTH INJURY 5 0.0033
222 TONSILLITIS 17 0.0033
223 BREATH SOUNDS ABNORMAL 16 0.0032
224 INFUSION SITE BRUISING 7 0.0032
225 PRODUCT PRESCRIBING ERROR 77 0.0032
226 TOOTH INJURY 14 0.0032
227 TONGUE INJURY 3 0.0032
228 DELAYED RECOVERY FROM ANAESTHESIA 3 0.0032
229 BODY TEMPERATURE DECREASED 31 0.0031
230 BRONCHIAL SECRETION RETENTION 4 0.0031
231 BODY HEIGHT BELOW NORMAL 2 0.0031
232 ADENOVIRUS INFECTION 9 0.0031
233 AORTIC VALVE DISEASE 5 0.0031
234 RETINAL DEGENERATION 4 0.0031
235 OBSTRUCTIVE AIRWAYS DISORDER 34 0.0031
236 THROMBOSIS IN DEVICE 10 0.0030
237 RESPIRATION ABNORMAL 21 0.0030
238 SPUTUM RETENTION 3 0.0030
239 BRONCHITIS VIRAL 2 0.0030
240 BEHAVIOUR DISORDER 16 0.0030
241 EXPOSURE TO SARS-COV-2 5 0.0029
242 SNORING 11 0.0029
243 BLOOD IMMUNOGLOBULIN E INCREASED 7 0.0029
244 HAEMATOLOGICAL INFECTION 7 0.0029
245 INFUSION SITE DISCHARGE 5 0.0028
246 H1N1 INFLUENZA 4 0.0028
247 GLASSY EYES 2 0.0028
248 FACIAL DISCOMFORT 2 0.0028
249 ALLERGY TO ANIMAL 3 0.0028
250 JOINT CONTRACTURE 3 0.0028
251 ANTIBODY TEST ABNORMAL 2 0.0028
252 APALLIC SYNDROME 2 0.0028
253 SCOLIOSIS 17 0.0027
254 PILOERECTION 3 0.0027
255 ESCHAR 2 0.0027
256 BRAIN CONTUSION 2 0.0027
257 DIET REFUSAL 2 0.0027
258 CRYPTORCHISM 3 0.0027
259 ANAPHYLACTOID REACTION 11 0.0027
260 STENOSIS 5 0.0027
261 ASPIRATION 29 0.0026
262 HYPERTHERMIA 20 0.0026
263 MASTICATION DISORDER 8 0.0026
264 FOLATE DEFICIENCY 3 0.0026
265 AORTIC VALVE INCOMPETENCE 11 0.0026
266 INFUSION SITE INFECTION 6 0.0026
267 PRURITUS ALLERGIC 3 0.0026
268 APNOEA 20 0.0026
269 RESTRICTIVE PULMONARY DISEASE 3 0.0026
270 HYPERAEMIA 5 0.0025
271 DRUG DELIVERY SYSTEM ISSUE 5 0.0025
272 CHOKING 49 0.0025
273 PNEUMONIA VIRAL 8 0.0025
274 PRODUCTIVE COUGH 119 0.0025
275 BLOOD IMMUNOGLOBULIN G INCREASED 3 0.0025
276 DENTAL DISCOMFORT 2 0.0024
277 INFUSION SITE ERYTHEMA 20 0.0024
278 FACE INJURY 9 0.0024
279 SCREAMING 15 0.0024
280 DEAFNESS BILATERAL 4 0.0024
281 ENDOCARDITIS 12 0.0023
282 ATONIC SEIZURES 2 0.0023
283 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 415 0.0023
284 RESTLESSNESS 83 0.0023
285 KYPHOSIS 4 0.0023
286 CATHETER MANAGEMENT 2 0.0022
287 ABDOMINAL RIGIDITY 6 0.0022
288 SALIVARY HYPERSECRETION 22 0.0022
289 VIRAL INFECTION 73 0.0022
290 RESPIRATORY SYNCYTIAL VIRUS INFECTION 19 0.0022
291 RHINORRHOEA 141 0.0022
292 PALLOR 59 0.0022
293 BONE CYST 2 0.0021
294 TACHYPNOEA 29 0.0021
295 TONIC CONVULSION 3 0.0021
296 INFLUENZA 234 0.0021
297 DECUBITUS ULCER 17 0.0021
298 RESPIRATORY TRACT CONGESTION 33 0.0021
299 EPILEPSY 63 0.0021
300 SPINAL CORD COMPRESSION 8 0.0021
301 PULMONARY VALVE INCOMPETENCE 3 0.0021
302 INFUSION SITE INDURATION 3 0.0020
303 CEREBRAL ATROPHY 8 0.0020
304 VEIN DISORDER 10 0.0020
305 DENTAL CARIES 22 0.0020
306 DROWNING 2 0.0020
307 CATHETER RELATED INFECTION 2 0.0020
308 OXYGEN SATURATION DECREASED 111 0.0020
309 BRONCHIAL DISORDER 3 0.0019
310 BODY TEMPERATURE FLUCTUATION 4 0.0019
311 SEIZURE 217 0.0019
312 TREATMENT NONCOMPLIANCE 102 0.0019
313 DEVICE OCCLUSION 26 0.0018
314 ACARODERMATITIS 2 0.0018
315 POOR QUALITY SLEEP 39 0.0018
316 PYREXIA 618 0.0018
317 CATHETER RELATED COMPLICATION 2 0.0018
318 GASTROENTERITIS VIRAL 32 0.0018
319 BACTERAEMIA 21 0.0018
320 RENAL COLIC 4 0.0018
321 ACUTE RESPIRATORY FAILURE 34 0.0018
322 BRONCHOPNEUMONIA 6 0.0018
323 GASTROINTESTINAL BACTERIAL INFECTION 2 0.0017
324 PERIORBITAL OEDEMA 9 0.0017
325 UPPER RESPIRATORY TRACT CONGESTION 5 0.0017
326 ASPHYXIA 14 0.0017
327 BRONCHIOLITIS 6 0.0017
328 GLOMERULONEPHRITIS MEMBRANOUS 2 0.0017
329 MITRAL VALVE DISEASE 3 0.0017
330 SKIN ABRASION 8 0.0017
331 FEAR OF DISEASE 3 0.0017
332 PRODUCT DOSE OMISSION ISSUE 495 0.0017
333 INFUSION SITE REACTION 5 0.0017
334 BLOOD CULTURE POSITIVE 5 0.0017
335 TOOTH ABSCESS 17 0.0017
336 STARING 4 0.0017
337 DEVICE ALARM ISSUE 3 0.0017
338 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
339 INFUSION SITE PAIN 21 0.0016
340 LARYNGEAL OEDEMA 10 0.0016
341 BLOOD UREA DECREASED 2 0.0016
342 NASAL OBSTRUCTION 3 0.0016
343 AORTIC VALVE REPLACEMENT 2 0.0016
344 INVESTIGATION 5 0.0016
345 INFUSION SITE PRURITUS 5 0.0016
346 BONE MARROW TRANSPLANT 3 0.0016
347 CRYING 57 0.0016
348 HEPATOSPLENOMEGALY 4 0.0016
349 CARDIO-RESPIRATORY ARREST 65 0.0016
350 RALES 9 0.0015
351 PRODUCT SUPPLY ISSUE 11 0.0015
352 HERNIA REPAIR 4 0.0015
353 TENDON DISORDER 10 0.0015
354 MULTIPLE ALLERGIES 12 0.0015
355 SLEEP APNOEA SYNDROME 29 0.0015
356 MITRAL VALVE INCOMPETENCE 17 0.0015
357 AGITATION 110 0.0015
358 EAR PAIN 29 0.0015
359 WEIGHT BEARING DIFFICULTY 4 0.0015
360 ILLNESS 153 0.0015
361 HEAD TITUBATION 2 0.0015
362 UPPER RESPIRATORY TRACT INFECTION 67 0.0014
363 NASAL CONGESTION 85 0.0014
364 PSYCHOMOTOR HYPERACTIVITY 24 0.0014
365 DISCHARGE 2 0.0014
366 OROPHARYNGEAL DISCOMFORT 13 0.0014
367 INTRACRANIAL PRESSURE INCREASED 8 0.0014
368 INCORRECT DOSAGE ADMINISTERED 7 0.0014
369 MALNUTRITION 16 0.0014
370 EAR PRURITUS 5 0.0014
371 AUDITORY DISORDER 2 0.0014
372 POST PROCEDURAL COMPLICATION 27 0.0014
373 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
374 HEART VALVE INCOMPETENCE 4 0.0014
375 PERIODONTITIS 3 0.0014
376 RESPIRATORY FAILURE 101 0.0014
377 TOOTHACHE 25 0.0014
378 GASTROENTERITIS 20 0.0014
379 ASTHMATIC CRISIS 5 0.0014
380 PRODUCT TEMPERATURE EXCURSION ISSUE 7 0.0014
381 EATING DISORDER 29 0.0014
382 PARTIAL SEIZURES 7 0.0013
383 GENERALISED TONIC-CLONIC SEIZURE 22 0.0013
384 DISEASE COMPLICATION 6 0.0013
385 PNEUMONIA BACTERIAL 12 0.0013
386 LOWER RESPIRATORY TRACT INFECTION 59 0.0013
387 TALIPES 4 0.0013
388 PNEUMONIA ASPIRATION 32 0.0013
389 AUTISM SPECTRUM DISORDER 7 0.0013
390 INGROWING NAIL 3 0.0013
391 RESPIRATORY ARREST 35 0.0013
392 FURUNCLE 10 0.0013
393 WRONG DOSE 3 0.0012
394 PERIPHERAL COLDNESS 17 0.0012
395 SCRATCH 13 0.0012
396 DRUG SPECIFIC ANTIBODY PRESENT 8 0.0012
397 POSTURE ABNORMAL 4 0.0012
398 BEDRIDDEN 16 0.0012
399 EXTRAVASATION 5 0.0012
400 DENTAL OPERATION 3 0.0012
401 EYELID OEDEMA 14 0.0012
402 GASTROINTESTINAL TUBE INSERTION 3 0.0012
403 HERNIA 23 0.0012
404 BRAIN ABSCESS 3 0.0012
405 DEAFNESS 31 0.0012
406 COVID-19 207 0.0012
407 PETIT MAL EPILEPSY 6 0.0012
408 ODYNOPHAGIA 7 0.0012
409 PULMONARY CONGESTION 15 0.0011
410 GENERALISED OEDEMA 14 0.0011
411 IRRITABILITY 68 0.0011
412 ANIMAL BITE 3 0.0011
413 ANAESTHETIC COMPLICATION 3 0.0011
414 LARYNGOSPASM 3 0.0011
415 COUGH 312 0.0011
416 PHARYNGITIS STREPTOCOCCAL 12 0.0011
417 EAR CONGESTION 3 0.0011
418 BLOOD PRESSURE ABNORMAL 22 0.0011
419 ABDOMINAL HERNIA 5 0.0011
420 STOMA SITE DISCHARGE 3 0.0011
421 MOUTH HAEMORRHAGE 8 0.0011
422 MEDICAL DEVICE COMPLICATION 8 0.0011
423 AGGRESSION 54 0.0011
424 TIBIA FRACTURE 5 0.0011
425 CEREBRAL THROMBOSIS 3 0.0011
426 SPINAL COLUMN STENOSIS 5 0.0011
427 DERMATITIS CONTACT 12 0.0011
428 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
429 COMMUNICATION DISORDER 4 0.0010
430 BODY HEIGHT DECREASED 11 0.0010
431 ATROPHY 2 0.0010
432 DEVICE POWER SOURCE ISSUE 3 0.0010
433 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
434 ORAL INFECTION 4 0.0010
435 NECK INJURY 3 0.0010
436 TOOTH DISCOLOURATION 3 0.0010
437 GROWTH RETARDATION 3 0.0010
438 DROOLING 7 0.0010
439 HEAD INJURY 32 0.0010
440 NASOPHARYNGITIS 186 0.0010
441 EMPYEMA 2 0.0010
442 HYPERNATRAEMIA 5 0.0010
443 ATYPICAL PNEUMONIA 3 0.0010
444 FLUID INTAKE REDUCED 5 0.0010
445 HYPERCAPNIA 3 0.0010
446 CRANIOCEREBRAL INJURY 3 0.0010
447 KLEBSIELLA INFECTION 5 0.0010
448 EYE INJURY 3 0.0010
449 TOOTH INFECTION 13 0.0010
450 URTICARIA 165 0.0010
451 NERVOUS SYSTEM DISORDER 30 0.0010
452 BLOOD CREATININE DECREASED 3 0.0010
453 WEIGHT FLUCTUATION 10 0.0010
454 DERMATITIS ALLERGIC 12 0.0010
455 SENSITIVITY TO WEATHER CHANGE 5 0.0009
456 DEVICE CONNECTION ISSUE 2 0.0009
457 TESTICULAR PAIN 3 0.0009
458 HYPERPYREXIA 4 0.0009
459 LIP OEDEMA 4 0.0009
460 PRODUCT DISPENSING ISSUE 4 0.0009
461 BRUXISM 5 0.0009
462 PNEUMONIA 300 0.0009
463 CHEILITIS 5 0.0009
464 TACHYCARDIA 82 0.0009
465 ACCIDENT 11 0.0009
466 HYPOVENTILATION 3 0.0009
467 PRODUCT PREPARATION ISSUE 6 0.0009
468 PROCEDURAL COMPLICATION 7 0.0009
469 FAECALOMA 5 0.0009
470 NEAR DEATH EXPERIENCE 3 0.0009
471 BRONCHITIS 67 0.0009
472 SKIN INJURY 3 0.0009
473 WHEELCHAIR USER 4 0.0009
474 TOOTH DISORDER 20 0.0009
475 TERMINAL STATE 6 0.0009
476 HYPOTHERMIA 9 0.0009
477 GENERALISED ERYTHEMA 5 0.0009
478 ECCHYMOSIS 6 0.0009
479 GRAND MAL CONVULSION 8 0.0009
480 WEIGHT INCREASED 194 0.0009
481 LOCALISED OEDEMA 4 0.0009
482 AORTIC STENOSIS 3 0.0009
483 FEELING OF DESPAIR 4 0.0009
484 BACTERIAL INFECTION 16 0.0009
485 HEART RATE DECREASED 30 0.0009
486 SKIN DISCOLOURATION 39 0.0008
487 DEVICE ISSUE 76 0.0008
488 CONVULSION 48 0.0008
489 INCORRECT PRODUCT ADMINISTRATION DURATION 18 0.0008
490 FACE OEDEMA 14 0.0008
491 BRONCHITIS CHRONIC 2 0.0008
492 TOOTH FRACTURE 9 0.0008
493 PSEUDOMONAS INFECTION 7 0.0008
494 EYE OEDEMA 2 0.0008
495 HEPATOMEGALY 8 0.0008
496 WOUND HAEMORRHAGE 3 0.0008
497 STAPHYLOCOCCAL SEPSIS 4 0.0008
498 ARTHROPOD BITE 6 0.0008
499 CARDIAC MURMUR 7 0.0008
500 CHILLS 93 0.0008
501 STAPHYLOCOCCAL INFECTION 26 0.0008
502 BOWEL MOVEMENT IRREGULARITY 6 0.0008
503 GASTROINTESTINAL INFECTION 7 0.0008
504 GAIT INABILITY 26 0.0008
505 WHEEZING 46 0.0008
506 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 26 0.0008
507 CARDIAC ARREST 63 0.0008
508 INCONTINENCE 8 0.0008
509 TRICUSPID VALVE INCOMPETENCE 6 0.0008
510 CONJUNCTIVITIS 14 0.0008
511 APPENDICITIS 7 0.0007
512 GASTROINTESTINAL INJURY 2 0.0007
513 SURGERY 43 0.0007
514 ABNORMAL FAECES 6 0.0007
515 ARTHRITIS BACTERIAL 3 0.0007
516 SPINAL STENOSIS 3 0.0007
517 ATELECTASIS 7 0.0007
518 JOINT STIFFNESS 19 0.0007
519 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
520 STREPTOCOCCAL INFECTION 4 0.0007
521 SLEEP TERROR 3 0.0007
522 POOR PERIPHERAL CIRCULATION 3 0.0007
523 ABSCESS LIMB 3 0.0007
524 INTERVERTEBRAL DISC DISORDER 3 0.0007
525 HYPERTONIA 4 0.0007
526 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
527 HEART RATE INCREASED 69 0.0007
528 DYSPHAGIA 66 0.0007
529 INCORRECT DOSE ADMINISTERED 157 0.0007
530 FAECES SOFT 5 0.0007
531 URINE OUTPUT DECREASED 6 0.0007
532 TONGUE DISCOLOURATION 3 0.0007
533 PARONYCHIA 3 0.0007
534 HYPOXIA 24 0.0007
535 ABNORMAL BEHAVIOUR 27 0.0007
536 OROPHARYNGEAL PAIN 63 0.0007
537 BLOOD CREATINE INCREASED 3 0.0007
538 CREPITATIONS 2 0.0007
539 MYOCLONUS 8 0.0007
540 ANAPHYLACTIC REACTION 37 0.0007
541 SNEEZING 15 0.0007
542 LIMB INJURY 18 0.0007
543 BONE MARROW DISORDER 2 0.0007
544 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
545 CARDIOMEGALY 8 0.0006
546 DIASTOLIC DYSFUNCTION 2 0.0006
547 PRODUCT PRESCRIBING ISSUE 14 0.0006
548 SWELLING OF EYELID 4 0.0006
549 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
550 SEASONAL ALLERGY 9 0.0006
551 PRODUCT USE COMPLAINT 10 0.0006
552 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
553 INFLUENZA LIKE ILLNESS 52 0.0006
554 MUSCLE ATROPHY 8 0.0006
555 GENERAL PHYSICAL HEALTH DETERIORATION 73 0.0006
556 RASH MACULAR 22 0.0006
557 MOVEMENT DISORDER 20 0.0006
558 HYPOKINESIA 9 0.0006
559 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
560 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
561 NASAL POLYPS 3 0.0006
562 OEDEMA 33 0.0006
563 LIGAMENT SPRAIN 6 0.0006
564 FOOT OPERATION 3 0.0006
565 MUCOUS STOOLS 3 0.0006
566 PROTEIN URINE PRESENT 3 0.0006
567 POST PROCEDURAL HAEMORRHAGE 7 0.0006
568 INFLAMMATION 31 0.0006
569 LIP SWELLING 20 0.0006
570 CARDIAC FAILURE ACUTE 4 0.0006
571 MENINGITIS 4 0.0006
572 MOBILITY DECREASED 43 0.0006
573 COVID-19 PNEUMONIA 7 0.0006
574 FEMORAL NECK FRACTURE 3 0.0006
575 EAR DISCOMFORT 6 0.0006
576 EYE MOVEMENT DISORDER 4 0.0006
577 ANURIA 5 0.0006
578 GRANULOMA 2 0.0006
579 PETECHIAE 6 0.0006
580 LOWER LIMB FRACTURE 11 0.0006
581 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
582 NYSTAGMUS 3 0.0006
583 THERMAL BURN 4 0.0006
584 RETCHING 12 0.0006
585 FEAR OF INJECTION 4 0.0006
586 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
587 FACIAL PAIN 5 0.0006
588 SUBDURAL HAEMATOMA 8 0.0006
589 DISEASE PROGRESSION 66 0.0006
590 BLOOD PRESSURE DECREASED 37 0.0006
591 ANAL INCONTINENCE 5 0.0006
592 BRAIN OEDEMA 7 0.0006
593 ERYTHEMA OF EYELID 3 0.0006
594 OSTEOMYELITIS 10 0.0006
595 SKIN LACERATION 6 0.0006
596 FEMUR FRACTURE 17 0.0005
597 HYPOPHAGIA 14 0.0005
598 FOOD INTOLERANCE 2 0.0005
599 GASTROINTESTINAL PAIN 6 0.0005
600 PRODUCT ADMINISTRATION ERROR 11 0.0005
601 HYPERKERATOSIS 3 0.0005
602 FEEDING DISORDER 11 0.0005
603 FOOT DEFORMITY 6 0.0005
604 CEREBRAL DISORDER 4 0.0005
605 TREMOR 89 0.0005
606 ACUTE PULMONARY OEDEMA 3 0.0005
607 ORAL CANDIDIASIS 7 0.0005
608 SARS-COV-2 TEST POSITIVE 7 0.0005
609 DEVICE DISLOCATION 23 0.0005
610 NEUROLOGICAL SYMPTOM 3 0.0005
611 DISCOMFORT 32 0.0005
612 FOOD ALLERGY 4 0.0005
613 THERAPY INTERRUPTED 37 0.0005
614 CONCUSSION 4 0.0005
615 SKIN WARM 3 0.0005
616 WEIGHT DECREASED 143 0.0005
617 SPINAL PAIN 6 0.0005
618 PULMONARY HAEMORRHAGE 4 0.0005
619 GAIT DISTURBANCE 97 0.0005
620 PRODUCT USE ISSUE 95 0.0005
621 INABILITY TO AFFORD MEDICATION 5 0.0005
622 MUSCLE RIGIDITY 6 0.0005
623 MASS 7 0.0005
624 HYPOTONIA 5 0.0005
625 FOREIGN BODY 2 0.0005
626 BLEPHARITIS 2 0.0005
627 TYPE 1 DIABETES MELLITUS 3 0.0005
628 TENSION 3 0.0005
629 COGNITIVE DISORDER 23 0.0005
630 HYPERSOMNIA 14 0.0005
631 HYPOACUSIS 21 0.0005
632 ILEUS 6 0.0005
633 TOOTH EXTRACTION 6 0.0005
634 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
635 CONGESTIVE CARDIOMYOPATHY 2 0.0005
636 SKIN LESION 13 0.0005
637 JOINT DISLOCATION 5 0.0005
638 RASH GENERALISED 12 0.0005
639 DYSPNOEA 262 0.0005
640 POLYP 3 0.0005
641 HAND DEFORMITY 6 0.0005
642 GROIN PAIN 4 0.0005
643 WALKING AID USER 3 0.0005
644 LOCALISED INFECTION 11 0.0005
645 MALAISE 199 0.0005
646 GINGIVAL SWELLING 2 0.0005
647 ABDOMINAL ABSCESS 2 0.0005
648 DRUG ERUPTION 8 0.0005
649 INTENTIONAL SELF-INJURY 9 0.0004
650 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
651 BONE DISORDER 8 0.0004
652 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 31 0.0004
653 MUSCLE TWITCHING 10 0.0004
654 APHASIA 13 0.0004
655 SWELLING FACE 28 0.0004
656 LUNG DISORDER 21 0.0004
657 UNRESPONSIVE TO STIMULI 11 0.0004
658 CARDIAC FAILURE 34 0.0004
659 HAND FRACTURE 3 0.0004
660 SPINAL DISORDER 4 0.0004
661 RECALLED PRODUCT ADMINISTERED 4 0.0004
662 EYE INFLAMMATION 4 0.0004
663 DYSKINESIA 17 0.0004
664 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
665 AFFECT LABILITY 4 0.0004
666 GUILLAIN-BARRE SYNDROME 2 0.0004
667 FLUSHING 42 0.0004
668 NEEDLE ISSUE 12 0.0004
669 ORAL DISORDER 3 0.0004
670 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
671 MUSCLE SPASTICITY 5 0.0004
672 MUSCULOSKELETAL DISCOMFORT 7 0.0004
673 SENSITIVE SKIN 3 0.0004
674 KNEE OPERATION 4 0.0004
675 HYDRONEPHROSIS 3 0.0004
676 DEVICE USE ISSUE 7 0.0004
677 ERYTHEMA 82 0.0004
678 MOTOR DYSFUNCTION 4 0.0004
679 SLUGGISHNESS 4 0.0004
680 HAEMATOMA 10 0.0004
681 VOMITING 179 0.0004
682 INFECTION 55 0.0004
683 PNEUMOTHORAX 6 0.0004
684 SUDDEN DEATH 4 0.0004
685 SOMNOLENCE 76 0.0004
686 FOOD POISONING 2 0.0004
687 DECREASED ACTIVITY 4 0.0004
688 SLEEP DISORDER 26 0.0004
689 PRODUCT DISPENSING ERROR 8 0.0004
690 ESCHERICHIA INFECTION 3 0.0004
691 ABASIA 9 0.0004
692 BLOOD PRESSURE INCREASED 55 0.0004
693 DEPRESSED MOOD 19 0.0004
694 FEELING COLD 10 0.0004
695 ROAD TRAFFIC ACCIDENT 15 0.0004
696 DEVICE MALFUNCTION 25 0.0004
697 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
698 EYE SWELLING 13 0.0003
699 ANAPHYLACTIC SHOCK 9 0.0003
700 LETHARGY 20 0.0003
701 ASTHMA 39 0.0003
702 HOSPITALISATION 53 0.0003
703 NERVOUSNESS 18 0.0003
704 SINUSITIS 35 0.0003
705 SPLENOMEGALY 4 0.0003
706 PRODUCT PREPARATION ERROR 7 0.0003
707 LUNG INFILTRATION 3 0.0003
708 ANGIOEDEMA 15 0.0003
709 BLOOD PRESSURE FLUCTUATION 8 0.0003
710 SEPSIS 37 0.0003
711 LIP DRY 3 0.0003
712 JOINT INJURY 7 0.0003
713 BRAIN NEOPLASM 3 0.0003
714 RASH 142 0.0003
715 NO ADVERSE EVENT 59 0.0003
716 NERVE COMPRESSION 3 0.0003
717 PROCEDURAL PAIN 9 0.0003
718 HEPATIC ENCEPHALOPATHY 3 0.0003
719 SYNCOPE 32 0.0003
720 BLOOD SODIUM DECREASED 6 0.0003
721 CELLULITIS 16 0.0003
722 SPUTUM DISCOLOURED 3 0.0003
723 ABDOMINAL DISTENSION 33 0.0003
724 FALL 105 0.0003
725 INSOMNIA 84 0.0003
726 DEATH 271 0.0003
727 HYPERSENSITIVITY 58 0.0003
728 SWELLING 29 0.0003
729 DYSSTASIA 9 0.0003
730 ORAL HERPES 6 0.0003
731 PHARYNGEAL SWELLING 3 0.0003
732 COELIAC DISEASE 3 0.0003
733 CORONAVIRUS INFECTION 2 0.0003
734 ADVERSE REACTION 4 0.0003
735 UPPER LIMB FRACTURE 6 0.0003
736 CARDIAC DISORDER 28 0.0003
737 BRAIN INJURY 3 0.0003
738 LACRIMATION INCREASED 9 0.0003
739 BRONCHIECTASIS 2 0.0003
740 CANDIDA INFECTION 5 0.0003
741 SINUS CONGESTION 4 0.0003
742 ABNORMAL LOSS OF WEIGHT 2 0.0003
743 RASH ERYTHEMATOUS 14 0.0003
744 DEHYDRATION 39 0.0003
745 WOUND 8 0.0003
746 MUSCULOSKELETAL STIFFNESS 25 0.0003
747 BLISTER 16 0.0003
748 COLD SWEAT 5 0.0003
749 GASTROINTESTINAL DISORDER 25 0.0003
750 DRUG DOSE OMISSION 46 0.0003
751 BALANCE DISORDER 24 0.0003
752 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
753 FLUID OVERLOAD 4 0.0003
754 PRODUCT STORAGE ERROR 24 0.0003
755 LOSS OF CONSCIOUSNESS 35 0.0003
756 ADVERSE EVENT 25 0.0003
757 BLINDNESS TRANSIENT 2 0.0003
758 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
759 CONTUSION 26 0.0003
760 URINARY INCONTINENCE 8 0.0003
761 ARTHROPATHY 15 0.0003
762 URINARY RETENTION 9 0.0003
763 EYE INFECTION 3 0.0003
764 DIARRHOEA 171 0.0003
765 FOOT FRACTURE 5 0.0003
766 HAEMODYNAMIC INSTABILITY 2 0.0003
767 NEOPLASM 3 0.0003
768 PERICARDIAL EFFUSION 6 0.0003
769 ATRIOVENTRICULAR BLOCK 2 0.0003
770 LUNG INFECTION 4 0.0003
771 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
772 DECREASED APPETITE 59 0.0003
773 BLOOD IRON DECREASED 3 0.0003
774 BLOOD ALBUMIN DECREASED 2 0.0003
775 ABSCESS 4 0.0003
776 PRESCRIBED UNDERDOSE 5 0.0003
777 BLOOD DISORDER 2 0.0002
778 CONSTIPATION 54 0.0002
779 FRUSTRATION TOLERANCE DECREASED 2 0.0002
780 MUSCLE TIGHTNESS 4 0.0002
781 DEVICE BREAKAGE 10 0.0002
782 BRADYCARDIA 13 0.0002
783 CYST 3 0.0002
784 HYPERHIDROSIS 31 0.0002
785 ATRIAL SEPTAL DEFECT 2 0.0002
786 DERMATITIS 5 0.0002
787 CONDITION AGGRAVATED 72 0.0002
788 ABDOMINAL PAIN 55 0.0002
789 CARDIOVASCULAR DISORDER 6 0.0002
790 URINARY TRACT INFECTION 40 0.0002
791 DRUG RESISTANCE 6 0.0002
792 SEPTIC SHOCK 10 0.0002
793 SPEECH DISORDER 12 0.0002
794 GRIP STRENGTH DECREASED 2 0.0002
795 LIMB DISCOMFORT 7 0.0002
796 UNEVALUABLE EVENT 17 0.0002
797 SWOLLEN TONGUE 7 0.0002
798 JOINT RANGE OF MOTION DECREASED 3 0.0002
799 HAEMOLYTIC ANAEMIA 2 0.0002
800 FEAR 6 0.0002
801 DEVELOPMENTAL DELAY 2 0.0002
802 BLINDNESS 9 0.0002
803 PNEUMONITIS 6 0.0002
804 GINGIVAL BLEEDING 3 0.0002
805 EXOSTOSIS 2 0.0002
806 APPLICATION SITE RASH 3 0.0002
807 DEFORMITY 2 0.0002
808 BLOOD TEST ABNORMAL 3 0.0002
809 INTESTINAL OBSTRUCTION 8 0.0002
810 FEELING HOT 13 0.0002
811 ARRHYTHMIA 10 0.0002
812 INTENTIONAL DOSE OMISSION 6 0.0002
813 PAIN 129 0.0002
814 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
815 GLAUCOMA 4 0.0002
816 ERUCTATION 4 0.0002
817 DYSTONIA 4 0.0002
818 APATHY 3 0.0002
819 VISUAL IMPAIRMENT 25 0.0002
820 HAEMORRHAGE INTRACRANIAL 3 0.0002
821 THROAT IRRITATION 9 0.0002
822 HAEMATOCHEZIA 11 0.0002
823 DRY THROAT 2 0.0002
824 PERIPHERAL SWELLING 30 0.0002
825 HYPOTENSION 39 0.0002
826 ANKLE FRACTURE 3 0.0002
827 TENDONITIS 3 0.0002
828 EYE DISCHARGE 2 0.0002
829 FOLLICULITIS 2 0.0002
830 PAIN IN EXTREMITY 56 0.0002
831 OBESITY 3 0.0002
832 DYSPHONIA 11 0.0002
833 THROMBOSIS 15 0.0002
834 THROAT TIGHTNESS 5 0.0002
835 ACNE 14 0.0002
836 DEVICE LEAKAGE 8 0.0002
837 HYPERTENSION 39 0.0002
838 CHOLELITHIASIS 6 0.0002
839 ILL-DEFINED DISORDER 11 0.0002
840 FUNGAL INFECTION 6 0.0002
841 ANXIETY 51 0.0002
842 RASH PAPULAR 4 0.0002
843 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
844 HEADACHE 110 0.0002
845 SCAR 3 0.0002
846 SKIN IRRITATION 8 0.0002
847 NEPHROLITHIASIS 8 0.0002
848 EPISTAXIS 13 0.0002
849 OEDEMA PERIPHERAL 21 0.0002
850 PANCREATITIS 9 0.0002
851 HEAD DISCOMFORT 3 0.0002
852 ISCHAEMIC STROKE 3 0.0002
853 ASTHENIA 62 0.0002
854 ADRENAL INSUFFICIENCY 2 0.0002
855 PRESYNCOPE 4 0.0002
856 PLEURAL EFFUSION 10 0.0002
857 PRURITUS 63 0.0002
858 DYSURIA 6 0.0002
859 NECK PAIN 9 0.0002
860 INCREASED APPETITE 3 0.0002
861 PULMONARY OEDEMA 7 0.0002
862 FATIGUE 121 0.0002
863 EYE DISORDER 5 0.0002
864 HYPOKALAEMIA 7 0.0002
865 UNDERDOSE 11 0.0002
866 STOMATITIS 9 0.0001
867 DISTURBANCE IN ATTENTION 8 0.0001
868 FREQUENT BOWEL MOVEMENTS 4 0.0001
869 ANGER 5 0.0001
870 RASH PRURITIC 8 0.0001
871 GASTRIC DISORDER 5 0.0001
872 HAEMORRHAGE 15 0.0001
873 HAEMOPTYSIS 4 0.0001
874 COORDINATION ABNORMAL 2 0.0001
875 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 29 0.0001
876 FAECES DISCOLOURED 3 0.0001
877 FEELING ABNORMAL 33 0.0001
878 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
879 CARDIOMYOPATHY 2 0.0001
880 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
881 RASH MACULO-PAPULAR 3 0.0001
882 CHROMATURIA 3 0.0001
883 APPLICATION SITE PRURITUS 3 0.0001
884 DEVICE FAILURE 2 0.0001
885 EJECTION FRACTION DECREASED 2 0.0001
886 MEDICATION ERROR 7 0.0001
887 MUSCULAR WEAKNESS 14 0.0001
888 BACK DISORDER 2 0.0001
889 PRODUCT DOSE OMISSION 8 0.0001
890 INJECTION SITE URTICARIA 3 0.0001
891 ABDOMINAL DISCOMFORT 20 0.0001
892 FLUID RETENTION 6 0.0001
893 CIRCULATORY COLLAPSE 2 0.0001
894 CHEST DISCOMFORT 12 0.0001
895 HAEMATURIA 4 0.0001
896 VERTIGO 7 0.0001
897 LYMPHADENOPATHY 4 0.0001
898 MUSCLE SPASMS 20 0.0001
899 CHEST PAIN 20 0.0001
900 DEMENTIA 3 0.0001
901 THROMBOCYTOPENIA 12 0.0001
902 ABDOMINAL PAIN UPPER 22 0.0001
903 FLATULENCE 6 0.0001
904 FRACTURE 2 0.0001
905 OCULAR HYPERAEMIA 5 0.0001
906 COMA 5 0.0001
907 ANGINA PECTORIS 3 0.0001
908 HAEMORRHOIDS 2 0.0001
909 DISABILITY 2 0.0001
910 ARTHRALGIA 42 0.0001
911 RENAL INJURY 3 0.0001
912 HAEMATOCRIT DECREASED 2 0.0001
913 COMPLICATION OF DEVICE INSERTION 2 0.0001
914 ADVERSE DRUG REACTION 9 0.0001
915 LEUKOPENIA 5 0.0001
916 INJURY 7 0.0001
917 EMOTIONAL DISTRESS 12 0.0001
918 OFF LABEL USE 86 0.0001
919 RENAL FAILURE 13 0.0001
920 DRY SKIN 13 0.0001
921 ECZEMA 5 0.0001
922 RENAL FAILURE ACUTE 4 0.0001
923 DIZZINESS 47 0.0001
924 METABOLIC ACIDOSIS 3 0.0001
925 MENTAL DISORDER 4 0.0001
926 IMPAIRED HEALING 3 0.0001
927 SKIN DISORDER 3 0.0001
928 PANCYTOPENIA 5 0.0001
929 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
930 CEREBRAL HAEMORRHAGE 3 0.0001
931 C-REACTIVE PROTEIN INCREASED 3 0.0001
932 DYSARTHRIA 3 0.0001
933 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
934 BACK PAIN 18 0.0001
935 CEREBROVASCULAR ACCIDENT 13 0.0001
936 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
937 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
938 HEPATIC ENZYME INCREASED 5 0.0001
939 BURNING SENSATION 5 0.0001
940 EYE IRRITATION 4 0.0001
941 NAUSEA 55 0.0001
942 ASCITES 2 0.0001
943 HYPOAESTHESIA 10 0.0001
944 RENAL DISORDER 3 0.0001
945 BONE DENSITY DECREASED 2 0.0001
946 CYSTITIS 2 0.0001
947 EXPIRED PRODUCT ADMINISTERED 2 0.0001
948 DRUG INEFFECTIVE 79 0.0001
949 MYALGIA 10 0.0001
950 THERAPY CESSATION 3 0.0001
951 HAEMOGLOBIN DECREASED 6 0.0001
952 JOINT SWELLING 7 0.0001
953 PLATELET COUNT DECREASED 6 0.0001
954 SUICIDAL IDEATION 5 0.0001
955 DYSPNOEA EXERTIONAL 2 0.0001
956 HALLUCINATION 4 0.0001
957 HOT FLUSH 4 0.0001
958 PULMONARY EMBOLISM 5 0.0001
959 ATRIAL FIBRILLATION 5 0.0001
960 BONE PAIN 3 0.0001
961 DYSPEPSIA 5 0.0001
962 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
963 DISORIENTATION 2 0.0001
964 CARDIAC FAILURE CONGESTIVE 4 0.0000
965 DEPRESSION 11 0.0000
966 ANAEMIA 9 0.0000
967 DEEP VEIN THROMBOSIS 3 0.0000
968 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
969 BLOOD CREATININE INCREASED 3 0.0000
970 INTENTIONAL PRODUCT MISUSE 4 0.0000
971 DEVICE DIFFICULT TO USE 3 0.0000
972 DISEASE RECURRENCE 2 0.0000
973 MIGRAINE 4 0.0000
974 BLOOD GLUCOSE DECREASED 2 0.0000
975 MYOCARDIAL INFARCTION 7 0.0000
976 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
977 RENAL IMPAIRMENT 3 0.0000
978 SKIN EXFOLIATION 3 0.0000
979 EYE PAIN 2 0.0000
980 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
981 PALPITATIONS 4 0.0000
982 CATARACT 2 0.0000
983 INJECTION SITE ERYTHEMA 4 0.0000
984 NEUROPATHY PERIPHERAL 3 0.0000
985 AMNESIA 2 0.0000
986 PRODUCT QUALITY ISSUE 4 0.0000
987 NEUTROPENIA 4 0.0000
988 OVERDOSE 6 0.0000
989 CHRONIC KIDNEY DISEASE 2 0.0000
990 DIABETES MELLITUS 2 0.0000
991 CONFUSIONAL STATE 4 0.0000
992 MEMORY IMPAIRMENT 3 0.0000
993 ACUTE KIDNEY INJURY 3 0.0000
994 PARAESTHESIA 3 0.0000